Infectious disease surveillance and the International Health Regulations
Infectious disease surveillance and the International Health Regulations
复制标题
DOI:
10.1002/9780470692097.ch2
复制
发表时间:
2007-01-01
期刊:
影响因子:
--
通讯作者:
Rodier, Guenael
中科院分区:
文献类型:
--
作者:
Plotkin, Bruce J.;Hardiman, Max;Rodier, Guenael
BackgroundFor over 35 years, the World Health Organization’s (WHO’s) International Health Regulations (“IHR” or “Regulations”) have been the primary legally binding global agreement addressing the risks of the international spread of infectious disease. However, the current 1969 Regulations (“IHR (1969)”)[1]—which remain in force generally until June 2007—are quite limited, dealing primarily with a small number of infectious diseases. To address these and other shortcomings in the IHR (1969), the World Health Assembly in 1995 adopted resolution WHA48. 7 that commenced the 10-year process of revising the Regulations to bring them up-to-date in policy and technology and to broaden their scope to address the transnational challenges presented by today’s increasingly globalized movements of trade, transport, and travelers. These newly revised IHR (2005) were adopted by the Health Assembly on May 23, 2005 [2], and will enter into force on June 15, 2007, for all WHO Member States who have not rejected them, or made certain reservations to them, by December 15, 2006 (see Table 2.1). The IHR (2005) completely revised and replaced the provisions concerning surveillance in the IHR (1969), providing broad new mandates and obligations for the “States Parties” to this new agreement and for WHO. The scope of coverage, including notification by States Parties and their obligations to respond to requests for verification by WHO, is expanded to include any event which may constitute a public health emergency of international concern (as well as certain other public health risks). Underlying the entire instrument is the new “purpose and scope” provision in Article 2, stating that the IHR (2005)“are to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade.”